Tag Archives: biogen idec

March, 2015

January, 2015

  • 29 January

    Biogen Partners to Develop Gene Therapies for Hemophilia

    Biogen Idec is teaming up with Fondazione Telethon and Ospedale San Raffaele to develop gene therapies for hemophilia A and B. The worldwide collaboration will combine San Raffaele-Telethon Institute for Gene Therapy’s (TIGET) extensive expertise in creating new gene therapy strategies and developing them from bench to bedside with Biogen’s …

  • 9 January

    Biogen’s anti-LINGO-1 Demonstrates Mixed Results in Study

    Biogen Idec said that its experimental multiple sclerosis (MS) drug showed signs that it could help repair nerve damage in patients’ eyes. The company announced top-line results from the Phase II acute optic neuritis (AON) RENEW trial. According to Biogen, treatment with its anti-LINGO-1 showed evidence of biological repair of …